Bo Lan

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Ejection Fraction

Prognostic Factors

Top Venues

International journal of cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Lv, Bo Lan, Li Zhang, Xiaoying Sun, Min Yang, Zongbi Yi
Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy-induced adverse events. Cancer medicine (2022)
Bo Lan, Nilupai Abudureheiyimu, Jingyi Zhang, Chenyu Wang, Shiyu Jiang, Jiayu Wang, Zongbi Yi, Yang Luo, Shanshan Chen, Binghe Xu, Ying Fan
Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China. International journal of cancer 147 (11) (2020)
Yimeng Chen, Yin Guan, Jiayu Wang, Zongbi Yi, Yang Luo, Shanshan Chen, Pin Zhang, Qing Li, Ruigang Cai, Qiao Li, Hongnan Mo, Bo Lan, Xuelian Chen, Weihong Zhao, Bing-He Xu, Ying Fan
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China. International journal of cancer 147 (12) (2020)
Bo Lan, Fei Ma, Xiaoyu Zhai, Qiao Li, Shanshan Chen, Jiayu Wang, Ying Fan, Yang Luo, Ruigang Cai, Peng Yuan, Pin Zhang, Qing Li, Binghe Xu
The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population. International journal of cancer 143 (1) (2018)
Bo Lan, Fei Ma, Shanshan Chen, Wenna Wang, Qiao Li, Ying Fan, Yang Luo, Ruigang Cai, Jiayu Wang, Peng Yuan, Pin Zhang, Qing Li, Binghe Xu
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China. International journal of cancer 143 (10) (2018)